NeuroOne Medical Technologies Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
NeuroOne Medical Technologies Corporation (NMTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $3.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-06-30 was $3.35, a 12.42% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $3.35, a 42.93% decline year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-12-31 was $0.58.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-06-30 was $2.98, a 496.00% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $0.50, a 53.70% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $1.08.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $3.00, a 30.07% decline from fiscal 2021.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $4.29, a 23.53% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.35 10-Q · filed 2026-08-13 | $3.38 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | $3.35 10-Q/A · filed 2026-06-12 | $3.35 10-Q/A · filed 2026-06-12 | ||||||
| 2025-12-31 | $0.58 10-Q · filed 2026-02-17 | |||||||
| 2025-09-30 | $0.50 10-K · filed 2025-12-17 | |||||||
| 2025-06-30 | $2.98 10-Q · filed 2026-08-13 | $0.50 10-Q · filed 2025-08-14 | $3.03 10-Q · filed 2026-08-13 | $0.50 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | $5.87 10-Q/A · filed 2026-06-12 | $0.98 10-Q · filed 2025-05-13 | $5.87 10-Q/A · filed 2026-06-12 | $0.98 10-Q · filed 2025-05-13 | ||||
| 2024-09-30 | $1.08 10-K · filed 2025-12-17 | |||||||
| 2024-06-30 | $0.50 10-Q · filed 2025-08-14 | $1.08 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | $0.91 10-Q · filed 2025-05-13 | $1.08 10-Q · filed 2025-05-13 | ||||||
| 2023-12-31 | $1.08 10-Q · filed 2024-02-13 | |||||||
| 2023-06-30 | $0.92 10-Q · filed 2024-08-14 | $0.88 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | $0.88 10-Q · filed 2024-05-14 | $0.75 10-Q · filed 2024-05-14 | ||||||
| 2022-12-31 | $0.66 10-Q · filed 2024-02-13 | |||||||
| 2022-09-30 | $3.00 10-K · filed 2022-12-22 | |||||||
| 2022-06-30 | $0.57 10-Q · filed 2022-08-11 | $0.76 10-Q · filed 2022-08-11 | ||||||
| 2022-03-31 | $1.03 10-Q · filed 2022-05-12 | |||||||
| 2021-09-30 | $3.00 10-K · filed 2023-12-15 | $4.29 10-K · filed 2022-12-22 | ||||||
| 2021-06-30 | $3.65 10-Q · filed 2022-08-11 | $3.01 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | $2.92 10-Q · filed 2022-05-12 | |||||||
| 2020-09-30 | $5.61 10-K/A · filed 2022-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |